Auro Laboratories (ARL) | Financial Analysis & Statements
Auro Laboratories Ltd. Small-cap Consumer Cyclical
TL;DR: Financial Overview - Revenue, Profits & Key Metrics
Latest Quarterly: Dec 2025Income Metrics
Revenue
1.3B
Gross Profit
73.2M
5.78%
Operating Income
47.3M
3.74%
Net Income
45.0M
3.55%
EPS (Diluted)
₹2.11
Balance Sheet Metrics
Total Assets
1.5B
Total Liabilities
538.6M
Shareholders Equity
966.2M
Debt to Equity
0.56
Cash Flow Metrics
Revenue & Profitability Trend
Quarter Income Flow
Dec 31, 2025
Annual Income Flow
2025
Auro Laboratories Income Statement From 2021 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | 3.1B | 3.4B | 3.4B | 3.3B | 2.1B |
| Cost of Goods Sold | 3.0B | 3.3B | 3.2B | 3.2B | 2.0B |
| Gross Profit | 130.0M | 133.9M | 120.9M | 121.5M | 72.0M |
| Gross Margin % | 4.1% | 3.9% | 3.6% | 3.6% | 3.5% |
| Operating Expenses | |||||
| Research & Development | - | - | 0 | 3.2K | 15.2K |
| Selling, General & Administrative | 33.6M | 34.4M | 30.2M | 23.3M | 19.1M |
| Other Operating Expenses | 2.5M | 2.3M | 590.9K | 1.1M | 780.5K |
| Total Operating Expenses | 36.1M | 36.7M | 30.7M | 24.4M | 19.9M |
| Operating Income | 72.1M | 71.4M | 72.0M | 79.7M | 36.9M |
| Operating Margin % | 2.3% | 2.1% | 2.1% | 2.4% | 1.8% |
| Non-Operating Items | |||||
| Interest Income | 912.5K | 661.4K | 994.7K | 650.3K | 2.1M |
| Interest Expense | 20.2M | 26.0M | 24.4M | 33.6M | 19.2M |
| Other Non-Operating Income | - | - | - | - | - |
| Pre-tax Income | 46.5M | 42.4M | 42.3M | 41.3M | 10.1M |
| Income Tax | 11.8M | 11.0M | 10.8M | 12.0M | 2.9M |
| Effective Tax Rate % | 25.3% | 26.1% | 25.5% | 28.9% | 28.9% |
| Net Income | 34.7M | 31.3M | 31.5M | 29.4M | 7.2M |
| Net Margin % | 1.1% | 0.9% | 0.9% | 0.9% | 0.3% |
| Key Metrics | |||||
| EBITDA | 69.9M | 70.6M | 69.3M | 76.0M | 30.2M |
| EPS (Basic) | ₹1.89 | ₹2.09 | ₹2.10 | ₹1.96 | ₹0.48 |
| EPS (Diluted) | ₹1.89 | ₹2.09 | ₹2.10 | ₹1.96 | ₹0.48 |
| Basic Shares Outstanding | 18382721 | 14984721 | 14984721 | 14984721 | 14984721 |
| Diluted Shares Outstanding | 18382721 | 14984721 | 14984721 | 14984721 | 14984721 |
Income Statement Trend
Join Our India Telegram Channel
Get Instant Market Updates: 52-Week High/Low Alerts, Breakout Notifications & Expert Stock Analysis Delivered To Your Phone. Join Traders Making Informed Decisions Daily!
Auro Laboratories Balance Sheet From 2021 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Assets | |||||
| Current Assets | |||||
| Cash & Equivalents | 236.4M | 150.3M | 47.6M | 391.8K | 820.1K |
| Short-term Investments | - | - | - | - | - |
| Accounts Receivable | 490.0M | 416.8M | 531.1M | 610.3M | 499.4M |
| Inventory | 143.7M | 66.1M | 62.1M | 73.7M | 60.6M |
| Other Current Assets | - | -1.0K | - | 166.4K | 5.2M |
| Total Current Assets | 965.8M | 723.9M | 746.5M | 777.0M | 678.0M |
| Non-Current Assets | |||||
| Property, Plant & Equipment | 0 | 0 | 3.5M | 0 | 3.9M |
| Goodwill | - | - | - | - | - |
| Intangible Assets | - | - | - | - | - |
| Long-term Investments | - | - | - | - | - |
| Other Non-Current Assets | 8.5M | 8.5M | 9.3M | 1.0K | - |
| Total Non-Current Assets | 23.3M | 18.1M | 13.6M | 12.3M | 11.8M |
| Total Assets | 989.1M | 742.0M | 760.1M | 789.4M | 689.8M |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts Payable | 41.4M | 70.3M | 67.5M | 154.8M | 47.8M |
| Short-term Debt | 121.2M | 236.2M | 264.0M | 235.3M | 262.8M |
| Current Portion of Long-term Debt | - | - | - | - | - |
| Other Current Liabilities | 5.4M | 7.9M | 10.0M | 10.0M | 7.9M |
| Total Current Liabilities | 180.3M | 325.8M | 352.7M | 412.4M | 321.7M |
| Non-Current Liabilities | |||||
| Long-term Debt | 39.9M | 53.7M | 76.2M | 77.3M | 97.8M |
| Deferred Tax Liabilities | - | - | - | - | - |
| Other Non-Current Liabilities | 1.0K | - | - | 6.0K | - |
| Total Non-Current Liabilities | 39.9M | 53.7M | 76.2M | 77.3M | 97.8M |
| Total Liabilities | 220.2M | 379.5M | 428.8M | 489.6M | 419.5M |
| Equity | |||||
| Common Stock | 183.8M | 149.8M | 149.8M | 149.8M | 149.8M |
| Retained Earnings | - | - | - | - | - |
| Treasury Stock | - | - | - | - | - |
| Other Equity | - | - | - | - | - |
| Total Shareholders Equity | 768.9M | 362.6M | 331.2M | 299.7M | 270.3M |
| Key Metrics | |||||
| Total Debt | 161.0M | 289.9M | 340.2M | 312.6M | 360.7M |
| Working Capital | 785.5M | 398.1M | 393.8M | 364.7M | 356.3M |
Balance Sheet Composition
Auro Laboratories Cash Flow Statement From 2021 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Operating Activities | |||||
| Net Income | 46.5M | 42.4M | 42.3M | 41.3M | 10.1M |
| Depreciation & Amortization | - | - | - | - | - |
| Stock-Based Compensation | - | - | - | - | - |
| Working Capital Changes | 80.2M | 100.9M | 101.1M | -98.6M | -36.1M |
| Operating Cash Flow | 151.5M | 171.1M | 170.7M | -19.9M | 822.8K |
| Investing Activities | |||||
| Capital Expenditures | -8.0M | -7.5M | -605.2K | -927.8K | -594.5K |
| Acquisitions | - | - | - | - | - |
| Investment Purchases | -236.3M | 0 | -25.0M | -1.5M | 0 |
| Investment Sales | 0 | 25.0M | 0 | 0 | 2.3M |
| Investing Cash Flow | -244.3M | 17.5M | -25.6M | -2.4M | 1.7M |
| Financing Activities | |||||
| Share Repurchases | - | - | - | - | - |
| Dividends Paid | - | - | - | - | - |
| Debt Issuance | 0 | 0 | 0 | 0 | 6.2M |
| Debt Repayment | -13.8M | -22.5M | -1.1M | -20.6M | 0 |
| Financing Cash Flow | 242.7M | -50.3M | 27.6M | -48.1M | 29.9M |
| Free Cash Flow | 104.3M | 154.9M | 71.7M | 86.3M | 1.3M |
| Net Change in Cash | 150.0M | 138.3M | 172.7M | -70.4M | 32.5M |
Cash Flow Trend
Auro Laboratories Key Financial Ratios
Valuation Ratios
P/E Ratio (TTM)
16.26
Price to Book
1.31
Price to Sales
0.32
PEG Ratio
0.06
Profitability Ratios
Profit Margin
2.06%
Operating Margin
3.74%
Return on Equity
4.52%
Return on Assets
3.51%
Financial Health
Current Ratio
2.90
Debt to Equity
30.40
Beta
0.24
Per Share Data
EPS (TTM)
₹3.66
Book Value per Share
₹45.37
Revenue per Share
₹173.65
Peer Financial Comparison
| Company | Market Cap | P/E Ratio | P/B Ratio | ROE | Profit Margin | Debt/Equity |
|---|---|---|---|---|---|---|
| ARL | 1.3B | 16.26 | 1.31 | 4.52% | 2.06% | 30.40 |
| KPR Mill | 317.5B | 37.48 | 5.92 | 16.30% | 12.72% | 6.46 |
| Vardhman Textiles | 170.7B | 21.02 | 1.65 | 8.86% | 8.08% | 14.47 |
| Sanathan Textiles | 36.6B | 36.89 | 1.98 | 8.87% | 2.95% | 77.61 |
| Raymond | 28.9B | 55.24 | 0.89 | 183.56% | 248.57% | 29.43 |
| Ganesha Ecosphere | 27.7B | 71.67 | 1.51 | 8.96% | 2.76% | 43.21 |
Financial data is updated regularly. All figures are in the company's reporting currency.




